Tampere, Finland

Sara Heinonen

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bayer Oy. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sara Heinonen. Retrieved from https://idiyas.com/inventor/sara-heinonen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0



Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

As an assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide information about inventor Sara Heinonen.

Title: Inventor Spotlight: Sara Heinonen

Introduction: Sara Heinonen is an innovative inventor based in Tampere, Finland.

Latest Patents: Sara Heinonen holds one patent for the "Ultrasonically detectable intrauterine system and a method for enhancing ultrasound detection." The invention focuses on improving the ultrasound detection of intrauterine systems by introducing an inert metal coating or clips.

Career Highlights: Sara Heinonen is affiliated with Bayer Oy, a renowned pharmaceutical company.

Collaborations: In her work, Sara Heinonen collaborates closely with her coworker Taina Tjäder, a talented woman in the field of innovations.

Conclusion: Sara Heinonen's groundbreaking work in enhancing ultrasound detection in intrauterine systems showcases her dedication to advancing medical technologies. Her collaboration with Taina Tjäder highlights the importance of teamwork in driving innovations forward in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…